AFJK Aimei Health Technology Co., Ltd.
Blank Checks · Nasdaq · SEC CIK 1979005 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$144,747 | -$192,348 | -$61,984 | -$250,589 | -$130,152 | -$41,604 | -$413,414 | -$402,021 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$30,848 | -$83,144 | $45,440 | $98,117 | $352,019 | $424,970 | $184,662 | $444,113 |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3,373 | $1,466 | $18,516 | $2,929 | $2,979 | $2,138 | $7,345 | $28,208 |
| Current assets | $51,396 | $43,966 | $18,707 | $2,929 | $24,948 | $44,638 | $8,022 | $30,384 |
| Total assets | $12.79M | $12.53M | $12.29M | $12.10M | $45.47M | $44.56M | $43.60M | $73.81M |
| Current liabilities | $4.13M | $3.84M | $3.52M | $3.37M | $2.77M | $2.21M | $1.69M | $816,994 |
| Total liabilities | $4.82M | $4.53M | $4.21M | $4.06M | $3.46M | $2.90M | $2.38M | $1.51M |
| Shareholders' equity | -$4.77M | -$4.48M | -$4.19M | -$4.06M | -$3.44M | -$2.86M | -$2.37M | -$1.48M |
| Shares outstanding | 2.13M | 2.13M | 2.13M | 2.13M | 2.13M | 2.13M | 2.13M | 2.13M |
| Cash flow statement | ||||||||
| Operating cash flow | -$346,293 | -$156,900 | -$74,613 | -$43,232 | -$96,109 | -$201,750 | -$224,009 | -$195,131 |
| Investing cash flow | -$137,324 | -$102,993 | -$68,662 | $33.69M | -$450,000 | -$450,000 | $30.79M | — |
| Financing cash flow | $485,524 | $242,843 | $158,862 | -$33.65M | $546,950 | $646,543 | -$30.58M | — |
Free plan shows the latest 8 periods; Pro shows all 11 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.